AVEO Pharma (AVEO) Misses Q4 EPS by 7c; Updates on Financial Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to AVEO Pharma (AVEO) Misses Q4 EPS by 7c; Updates on Financial Outlook

AVEO Oncology Reports Full Year 2015 Financial Results and Provides Business Update

March 15, 2016 7:30 AM EDT

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- AVEO Oncology (NASDAQ: AVEO) today reported financial results for the full year ended December 31, 2015 and provided a business update.

Over the course of 2015, AVEO has streamlined its organization and taken a fresh strategic direction to create increased shareholder value. In 2016, we are squarely focused on furthering the execution of this strategy, said Michael Bailey, president and chief executive officer. We remain focused on retaining rights to develop our three oncology-focused clinical programs in North America, while seeing our pipeline advanced by partners in the lab, clinic and through the... More